Safety and Efficacy Study of PRI-724 Plus Gemcitabine in Subjects With Advanced or Metastatic Pancreatic Adenocarcinoma

NCT01764477 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Pancreatic Cancer
Metastatic Pancreatic Cancer
Pancreatic Adenocarcinoma

Interventions

DRUG: PRI-724

Sponsor

Prism Pharma Co., Ltd.

Collaborators

[object Object]